Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05052580 · ClinicalTrials.gov registry record · NA

Test to Stay in School: COVID-19 Testing Following Exposure in School Communities

A NA study of COVID-19, sponsored by Duke University.

Completed
Registry status
NA
Development phase
4,733
Enrollment target
1
Study location

NCT05052580: Completed NA study of COVID-19, sponsored by Duke University.

NCT05052580 is a NA study of COVID-19 that has completed, run by Duke University. The registered enrollment target is 4,733 participants, below the 38,449-participant average among 298 other COVID-19 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05052580, a NA study of COVID-19, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
4,733 participants
Enrollment target
1
Study location

Study Summary

Participants in school communities who have been exposed to SARS-CoV-2 will be tested for COVID-19 on the day of exposure (day 1) and at days 3, 5, and 7 following initial known exposure. Mitigation practices including masking, the context of exposure (classroom, school bus, after school sporting event, lunch, etc.), and results of COVID-19 test will be documented.

Conditions Studied

Interventions

  • OTHER COVID-19 Testing

Study Locations (1)

North Carolina

  • Participating NC School Districts - Durham

Trial Details

FieldValue
Enrollment Target 4,733 participants
Start Date 2021-10-01
Est. Completion 2022-03-28
Phase NA
Duke University

1,725 total trials

What the finished NCT05052580 record still lists

NCT05052580 is an interventional study that assigns participants to a tested intervention. Its 4,733 participants enrollment target places it among the larger protocols in the corpus, below the 38,449-participant average among 298 other COVID-19 trials with a reported enrollment target (88% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 Testing is the first listed.

NCT05052580 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05052580 about?

NCT05052580 is a clinical study titled "Test to Stay in School: COVID-19 Testing Following Exposure in School Communities". Participants in school communities who have been exposed to SARS-CoV-2 will be tested for COVID-19 on the day of exposure (day 1) and at days 3, 5, and 7 following initial known exposure. Mitigation practices including masking, the context of exposure (classroom, school bus, after school sporting ev...

What is the current status of trial NCT05052580?

This trial is currently completed. It is a NA study. The enrollment target is 4,733 participants. The study started on 2021-10-01. Estimated completion is 2022-03-28.

What conditions does trial NCT05052580 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05052580?

The interventions under investigation include: COVID-19 Testing (OTHER).

Who is sponsoring clinical trial NCT05052580?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05052580 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05052580's enrollment target sits among peer trials

4,733 30th of 298 higher than 269 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04371900 · 4,700 participants · NA

    Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1

  • NCT05486572 · 4,700 participants · NA

    Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • NCT06888388 · 4,700 participants

    Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

  • NCT01719055 · 4,800 participants

    RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05052580, the US trial registry maintained by the National Library of Medicine. NCT05052580 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.